256940 — Keeps BioPharma Balance Sheet

0.000.00%

Last trade - 00:00

TechnologyHighly SpeculativeSmall CapNeutral

Annual balance sheet for Keeps BioPharma, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	31,702	40,889	30,475	14,624	24,405
Net Total Accounts Receivable
Net Total Receivables	17,130	19,350	10,576	17,086	20,593
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	50,077	63,342	43,310	46,766	70,714
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10,834	10,365	10,062	28,376	35,068
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	76,992	93,401	85,559	117,279	165,211
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	21,906	30,197	32,059	55,880	85,427
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	26,834	32,375	32,487	60,042	115,077
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	50,158	61,026	53,072	57,236	50,134
Total Liabilities & Shareholders' Equity	76,992	93,401	85,559	117,279	165,211
Total Common Shares Outstanding